Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis

PURPOSE: To re-evaluate the cardiovascular risk of lumiracoxib compared with other non-steroidal anti-inflammatory drugs (NSAIDs) or placebo in patients with osteoarthritis. METHODS: We conducted a meta-analysis of randomised controlled trials of lumiracoxib versus placebo or other NSAIDs in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Mackenzie, Isla S., Wei, Li, MacDonald, Thomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548096/
https://www.ncbi.nlm.nih.gov/pubmed/22732767
http://dx.doi.org/10.1007/s00228-012-1335-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548096/
https://www.ncbi.nlm.nih.gov/pubmed/22732767
http://dx.doi.org/10.1007/s00228-012-1335-1

Ejemplares similares